In-silico validation of novel therapeutic activities of withaferin a using molecular docking and dynamics studies

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Aggarwal, B. B., Ichikawa, H., Garodia, P., Weerasinghe, P., Sethi, G., Bhatt, I. D., Pandey, M. K., Shishodia, S., & Nair, M. G. (2006). From traditional Ayurvedic medicine to modern medicine: Identification of therapeutic targets for suppression of inflammation and cancer. Expert Opinion on Therapeutic Targets, 10(1), 87–118. https://doi.org/10.1517/14728222.10.1.87
   PubMed Web of Science ®Google Scholar
• Andrade, E. F., Lobato, R. V., De Araújo, T. V., Zangerônimo, M. G., De Sousa, R. V., & Pereira, L. J. (2015). Efecto de los beta-glucanos en el control de los niveles de glucosa en pacientes diabéticos: revisión sistemática. Nutricion Hospitalaria, 31(1), 170–177. https://doi.org/10.3305/nh.2015.31.1.7597
   Web of Science ®Google Scholar
• Angelica, M. D., & Fong, Y. (2008). Molecular mechanisms of Nrf2-mediated antioxidant response wenge. Journal of Molecular Biology, 141(4), 520–529. 10.1002/mc.20465.Molecular
   Google Scholar
• Bhardwaj, V. K., & Purohit, R. (2020). A new insight into protein-protein interactions and the effect of conformational alterations in PCNA. International Journal of Biological Macromolecules, 148, 999–1009. https://doi.org/10.1016/j.ijbiomac.2020.01.212
   PubMed Web of Science ®Google Scholar
• Bhattacharya, S. K., & Muruganandam, A. V. (2003). Adaptogenic activity of Withania somnifera: An experimental study using a rat model of chronic stress. Pharmacology, Biochemistry, and Behavior, 75(3), 547–555. https://doi.org/10.1016/S0091-3057(03)00110-2
   PubMed Web of Science ®Google Scholar
• Bikadi, Z., & Hazai, E. (2009). Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. Journal of Cheminformatics, 1(1), 15–16. https://doi.org/10.1186/1758-2946-1-15
   PubMed Web of Science ®Google Scholar
• Brooijmans, N., & Kuntz, I. D. (2003). Molecular recognition and docking algorithms. Annual Review of Biophysics and Biomolecular Structure, 32, 335–373. https://doi.org/10.1146/annurev.biophys.32.110601.142532
   PubMed Web of Science ®Google Scholar
• Carroll, M. D., & Lacher, A. (2010). Total and high-density lipoprotein cholesterol in adults: National Health and Nutrition Examination Survey, 2009–2010 (Vol. 92, pp. 1–8). U.S. Department of Health and Human services - Centers for Disease Control and Prevention National Center for Health Statistics.
   Google Scholar
• Chadwick, A. C., Jensen, D. R., Hanson, P. J., Lange, P. T., Proudfoot, S. C., Peterson, F. C., Volkman, B. F., & Sahoo, D. (2017). NMR structure of the C-terminal transmembrane domain of the HDL receptor, SR-BI, and a functionally relevant leucine zipper motif. Structure (London, England : 1993), 25(3), 446–457. https://doi.org/10.1016/j.str.2017.01.001
   PubMed Web of Science ®Google Scholar
• Davis, H. R., & Veltri, E. P. (2007). Zetia: Inhibition of Niemann-Pick C1 like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. Journal of Atherosclerosis and Thrombosis, 14(3), 99–108. https://doi.org/10.5551/jat.14.99
   PubMed Web of Science ®Google Scholar
• Deocaris, C. C., Lu, W.-J., C. Kaul, S., & Wadhwa, R. (2012). Druggability of mortalin for cancer and neuro-degenerative disorders. Current Pharmaceutical Design, 19(3), 418–429. https://doi.org/10.2174/13816128130308
   Web of Science ®Google Scholar
• Derosa, G., & Maffioli, P. (2012). α-Glucosidase inhibitors and their use in clinical practice. Archives of Medical Science : AMS, 8(5), 899–906. https://doi.org/10.5114/aoms.2012.31621
   PubMed Web of Science ®Google Scholar
• Ferguson, R. D., Gallagher, E. J., Scheinman, E. J., Damouni, R., & LeRoith, D. (2013). The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer. In Gerald Litwack (Ed.), Vitamins and hormones (1st ed., Vol. 93). Elsevier Inc. https://doi.org/10.1016/B978-0-12-416673-8.00010-1
   Google Scholar
• Gangadharappa, B. S., Sharath, R., Revanasiddappa, P. D., Chandramohan, V., Balasubramaniam, M., & Vardhineni, T. P. (2020). Structural insights of metallo-beta-lactamase revealed an effective way of inhibition of enzyme by natural inhibitors. Journal of Biomolecular Structure & Dynamics, 38(13), 3757–3771. https://doi.org/10.1080/07391102.2019.1667265
   PubMed Web of Science ®Google Scholar
• Ghani, U. (2015). Re-exploring promising α-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystack. European Journal of Medicinal Chemistry, 103, 133–162. https://doi.org/10.1016/j.ejmech.2015.08.043
   PubMed Web of Science ®Google Scholar
• Guedes, I. A., de Magalhães, C. S., & Dardenne, L. E. (2014). Receptor-ligand molecular docking. Biophysical Reviews, 6(1), 75–87. https://doi.org/10.1007/s12551-013-0130-2
   PubMedGoogle Scholar
• Hakamata, W., Kurihara, M., Okuda, H., Nishio, T., & Oku, T. (2009). Design and Screening Strategies for alpha-glucosidase inhibitors based on enzymological information . Current Topics in Medicinal Chemistry, 9(1), 3–12. https://doi.org/10.2174/156802609787354306
   PubMed Web of Science ®Google Scholar
• Halder, D., Das, S., Joseph, A., & Jeyaprakash, R. S. (2022). Molecular docking and dynamics approach to in silico drug repurposing for inflammatory bowels disease by targeting TNF alpha. Journal of Biomolecular Structure and Dynamics, 40, 1–14. https://doi.org/10.1080/07391102.2022.2050948
   PubMed Web of Science ®Google Scholar
• Halgren, T. A. (1996). Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. Journal of Computational Chemistry, 17(5–6), 520–552. https://doi.org/10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
   Google Scholar
• Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646–674. https://doi.org/10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Huang, C. S., Yu, X., Fordstrom, P., Choi, K., Chung, B. C., Roh, S. H., Chiu, W., Zhou, M., Min, X., & Wang, Z. (2020). Cryo-EM structures of NPC1L1 reveal mechanisms of cholesterol transport and ezetimibe inhibition. Science Advances, 6(25), 1–12. https://doi.org/10.1126/sciadv.abb1989
   Web of Science ®Google Scholar
• Jemal, A., Bray, F., & Ferlay, J. (1999). Global cancer statistics: 2011. CA: A Cancer Journal for Clinicians, 49(2), 33–64. https://doi.org/10.3322/caac.20107
   PubMedGoogle Scholar
• Jeong, S. M., Choi, S., Kim, K., Kim, S. M., Lee, G., Son, J. S., Yun, J. M., & Park, S. M. (2018). Association of change in total cholesterol level with mortality: A population-based study. Plos One, 13(4), e0196030. https://doi.org/10.1371/journal.pone.0196030
   PubMed Web of Science ®Google Scholar
• Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A., Sak, K., Srivastava, S., Pandey, A., Garg, V. K., Sethi, G., & Bishayee, A. (2021). Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. Seminars in Cancer Biology, 69, 5–23. https://doi.org/10.1016/j.semcancer.2019.08.014
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations . Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lo, S. C., Li, X., Henzl, M. T., Beamer, L. J., & Hannink, M. (2006). Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. The EMBO Journal, 25(15), 3605–3617. https://doi.org/10.1038/sj.emboj.7601243
   PubMed Web of Science ®Google Scholar
• Malaviya, A., Paari, K. A., Malviya, S., Kondapalli, V. K., Ghosh,., & A., S. R. A. (2021). Gut microbiota and cancer correlates. In Indu Pal Kaur (Editor-in-Chief) and Parneet Kaur Deol (Ed.), Probiotic research in therapeutics: Applications in cancers and immunological diseases (Vol. 1, pp. 1–27). Singapore: Springer.
   Google Scholar
• Matsuda, H., Murakami, T., Kishi, A., & Yoshikawa, M. (2001). Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorganic & Medicinal Chemistry, 9(6), 1499–1507. https://doi.org/10.1016/S0968-0896(01)00024-4
   PubMed Web of Science ®Google Scholar
• Maurya, R. (2010). Chemistry and pharmacology of Withania coagulans : An Ayurvedic remedy. The Journal of Pharmacy and Pharmacology, 62(2), 153–160. https://doi.org/10.1211/jpp.62.02.0001
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639–1662. https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14%3C1639::AID-JCC10%3E3.0.CO;2-B
   Web of Science ®Google Scholar
• Nguyen, T., Nioi, P., & Pickett, C. B. (2009). The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. The Journal of Biological Chemistry, 284(20), 13291–13295. https://doi.org/10.1074/jbc.R900010200
   PubMed Web of Science ®Google Scholar
• Panwar, H., Calderwood, D., Grant, I. R., Grover, S., & Green, B. D. (2014). Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential. European Journal of Nutrition, 53(7), 1465–1474. https://doi.org/10.1007/s00394-013-0649-9
   PubMed Web of Science ®Google Scholar
• Prasanth, D. S. N. B. K., Murahari, M., Chandramohan, V., Panda, S. P., Atmakuri, L. R., & Guntupalli, C. (2021). In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. Journal of Biomolecular Structure & Dynamics, 39(13), 4618–4632. https://doi.org/10.1080/07391102.2020.1779129
   PubMed Web of Science ®Google Scholar
• Purohit, R. (2014). Role of ELA region in auto-activation of mutant KIT receptor: A molecular dynamics simulation insight. Journal of Biomolecular Structure & Dynamics, 32(7), 1033–1046. https://doi.org/10.1080/07391102.2013.803264
   PubMed Web of Science ®Google Scholar
• Rai, M., Jogee, P. S., Agarkar, G., & Santos, C. A. D. (2016). Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives. Pharmaceutical Biology, 54(2), 189–197. https://doi.org/10.3109/13880209.2015.1027778
   PubMed Web of Science ®Google Scholar
• Roig-Zamboni, V., Cobucci-Ponzano, B., Iacono, R., Ferrara, M. C., Germany, S., Bourne, Y., Parenti, G., Moracci, M., & Sulzenbacher, G. (2017). Structure of human lysosomal acid α-glucosidase-A guide for the treatment of Pompe disease. Nature Communications, 8(1), 1-8. https://doi.org/10.1038/s41467-017-01263-3
   Google Scholar
• Rutwick Surya, U., & Praveen, N. (2021). A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery. Virusdisease, 32(1), 46–54. https://doi.org/10.1007/s13337-021-00683-6
   PubMedGoogle Scholar
• Saleem, S., Muhammad, G., Hussain, M. A., Altaf, M., & Abbas Bukhari, S. N. (2020). Withania somnifera L.: Insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective. Iranian Journal of Basic Medical Sciences, 23(12), 1501–1526. https://doi.org/10.22038/ijbms.2020.44254.10378[33489024
   PubMed Web of Science ®Google Scholar
• Sari, A. N., Bhargava, P., Dhanjal, J. K., Putri, J. F., Radhakrishnan, N., Shefrin, S., Ishida, Y., Terao, K., Sundar, D., Kaul, S. C., & Wadhwa, R. (2020). Combination of withaferin-A and CAPE provides superior anticancer potency: Bioinformatics and experimental evidence to their molecular targets and mechanism of action. Cancers, 12(5), 1160–1125. https://doi.org/10.3390/cancers12051160
   PubMed Web of Science ®Google Scholar
• Schüttelkopf, A. W., & Van Aalten, D. M. F. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica. Section D, Biological Crystallography, 60(Pt 8), 1355–1363. https://doi.org/10.1107/S0907444904011679
   PubMedGoogle Scholar
• Sever, R., & Brugge, J. S. (2015). Genetic and epigenetic mechanisms of cancer progression. Cold Spring Harbor Perspectives in Medicine, 5(4), A006098–21. https://doi.org/10.1101/cshperspect.a006098
   PubMed Web of Science ®Google Scholar
• Sharma, A., Shanker, C., Tyagi, L. K., Singh, M., & Rao, C. V. (2008). Herbal medicine for market potential in India: An overview. Academic Journal of Plant, 1(2), 26–36.
   Google Scholar
• Shen, W. J., Azhar, S., & Kraemer, F. B. (2018). SR-B1: A unique multifunctional receptor for cholesterol influx and efflux. Annual Review of Physiology, 80, 95–116. https://doi.org/10.1146/annurev-physiol-021317-121550
   PubMed Web of Science ®Google Scholar
• Solis, F. J., & Wets, R. J. B. (1981). Minimization by random search techniques. Mathematics of Operations Research, 6(1), 19–30. https://doi.org/10.1287/moor.6.1.19
   Web of Science ®Google Scholar
• Surya, U. R., Naik, P. M., Vinayak, U., & Praveen, N. (2021). A critical review of anticancer properties of Withania somnifera (L.) Dunal with respect to the biochemical mechanisms of its phytochemical constituents. Plant Science Today, 8(2), 236–249. https://doi.org/10.14719/pst.2021.8.2.969
   Web of Science ®Google Scholar
• Szarc Vel Szic, K., Op De Beeck, K., Ratman, D., Wouters, A., Beck, I. M., Declerck, K., Heyninck, K., Fransen, E., Bracke, M., De Bosscher, K., Lardon, F., Van Camp, G., & Vanden Berghe, W. (2014). Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells. PLoS ONE, 9(2), e87850. https://doi.org/10.1371/journal.pone.0087850
   PubMed Web of Science ®Google Scholar
• Tribolo, S., Berrin, J. G., Kroon, P. A., Czjzek, M., & Juge, N. (2007). The Crystal Structure of Human Cytosolic beta-glucosidase unravels the substrate aglycone specificity of a family 1 glycoside hydrolase . Journal of Molecular Biology, 370(5), 964–975. (https://doi.org/10.1016/j.jmb.2007.05.034
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. (2020). National Diabetes Statistics Report, 2020. National Diabetes Statistics Report, 2.
   Google Scholar
• Vaishnavi, K., Saxena, N., Shah, N., Singh, R., Manjunath, K., Uthayakumar, M., Kanaujia, S. P., Kaul, S. C., Sekar, K., & Wadhwa, R. (2012). Differential activities of the two closely related withanolides, Withaferin A and Withanone: Bioinformatics and experimental evidences. PLoS ONE, 7(9), e44419. https://doi.org/10.1371/journal.pone.0044419
   PubMed Web of Science ®Google Scholar
• Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009). Diabetes and cancer. Endocrine-Related Cancer, 16(4), 1103–1123. https://doi.org/10.1677/ERC-09-0087
   PubMed Web of Science ®Google Scholar
• Widodo, N., Takagi, Y., Shrestha, B. G., Ishii, T., Kaul, S. C., & Wadhwa, R. (2008). Selective killing of cancer cells by leaf extract of Ashwagandha: Components, activity and pathway analyses. Cancer Letters, 262(1), 37–47. https://doi.org/10.1016/j.canlet.2007.11.037
   PubMed Web of Science ®Google Scholar
• Yang, L., Li, H., Jiang, Y., Zuo, J., & Liu, W. (2013). Inhibition of mortalin expression reverses cisplatin resistance and attenuates growth of ovarian cancer cells. Cancer Letters, 336(1), 213–221. https://doi.org/10.1016/j.canlet.2013.05.004
   PubMed Web of Science ®Google Scholar
• Yun, C. O., Bhargava, P., Na, Y., Lee, J. S., Ryu, J., Kaul, S. C., & Wadhwa, R. (2017). Relevance of mortalin to cancer cell stemness and cancer therapy. Scientific Reports, 7, 42016–42010. https://doi.org/10.1038/srep42016
   PubMed Web of Science ®Google Scholar
• Zimmet, P. Z., Magliano, D. J., Herman, W. H., & Shaw, J. E. (2014). Diabetes: A 21st century challenge. The Lancet. Diabetes & Endocrinology, 2(1), 56–64. https://doi.org/10.1016/S2213-8587(13)70112-8
   PubMed Web of Science ®Google Scholar